全文获取类型
收费全文 | 12341篇 |
免费 | 1322篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 98篇 |
儿科学 | 335篇 |
妇产科学 | 327篇 |
基础医学 | 1810篇 |
口腔科学 | 268篇 |
临床医学 | 1438篇 |
内科学 | 2114篇 |
皮肤病学 | 138篇 |
神经病学 | 1268篇 |
特种医学 | 383篇 |
外国民族医学 | 1篇 |
外科学 | 1816篇 |
综合类 | 205篇 |
一般理论 | 7篇 |
预防医学 | 1470篇 |
眼科学 | 201篇 |
药学 | 860篇 |
中国医学 | 18篇 |
肿瘤学 | 931篇 |
出版年
2022年 | 126篇 |
2021年 | 250篇 |
2020年 | 129篇 |
2019年 | 197篇 |
2018年 | 239篇 |
2017年 | 188篇 |
2016年 | 176篇 |
2015年 | 242篇 |
2014年 | 324篇 |
2013年 | 454篇 |
2012年 | 671篇 |
2011年 | 630篇 |
2010年 | 297篇 |
2009年 | 328篇 |
2008年 | 593篇 |
2007年 | 545篇 |
2006年 | 543篇 |
2005年 | 558篇 |
2004年 | 512篇 |
2003年 | 463篇 |
2002年 | 432篇 |
2001年 | 366篇 |
2000年 | 388篇 |
1999年 | 342篇 |
1998年 | 125篇 |
1997年 | 127篇 |
1996年 | 118篇 |
1995年 | 105篇 |
1994年 | 108篇 |
1993年 | 91篇 |
1992年 | 260篇 |
1991年 | 229篇 |
1990年 | 253篇 |
1989年 | 251篇 |
1988年 | 224篇 |
1987年 | 214篇 |
1986年 | 209篇 |
1985年 | 217篇 |
1984年 | 169篇 |
1983年 | 137篇 |
1982年 | 123篇 |
1981年 | 97篇 |
1980年 | 91篇 |
1979年 | 146篇 |
1978年 | 126篇 |
1977年 | 101篇 |
1976年 | 95篇 |
1974年 | 103篇 |
1973年 | 108篇 |
1970年 | 82篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
D C Carter 《Surgery》1992,111(6):602-603
62.
M Kawai D A Quincy B Lane K W Mollison Y S Or J R Luly G W Carter 《Journal of medicinal chemistry》1992,35(2):220-223
The synthesis and structure-activity relationships of C-terminal octapeptide analogues of anaphylatoxin C5a have been studied. The introduction of hydrophobic amino acids into the N-acetylated native octapeptide (N-Ac-His-Lys-Asp-Met-Gln-Leu-Gly-Arg-OH) (1) has led to an analogue with 100 times more activity than the native octapeptide in inhibiting the binding of 125I-labeled anaphylatoxin C5a to human neutrophil membrane receptors. The observed apparent binding Ki's for the compounds (8-10) are in the range of 1-3 microM, and they possess nearly full agonist activity, despite the fact that these analogues are one-eighth or -ninth the size of the natural ligand anaphylatoxin C5a. 相似文献
63.
Oluseun A Sowemimo Steven M Yood John Courtney Jessie Moore Miriam Huang Rebecca Ross Ursula McMillian Peter Ojo Randolph B Reinhold 《Surgery for obesity and related diseases》2007,3(1):73-7; discussion 77
BACKGROUND: To study the mortality among morbidly obese patients qualifying for bariatric surgery. Mortality from bariatric surgery for morbid obesity has been widely reported; however, little is known about the mortality in morbidly obese patients who defer surgery. METHODS: Consecutive patients evaluated for bariatric surgery with an initial encounter between 1997 and 2004 were identified. The Social Security Death Index and office records were used to identify mortality through 2006. We conducted telephone interviews to determine whether the 305 patients who did not undergo bariatric surgery at our institution had undergone the surgery elsewhere. Using Cox proportional hazards models, we compared the mortality in patients undergoing surgery with that of those who did not. To evaluate bias resulting from missing data, we conducted analyses assuming that all patients with missing data had (1) undergone surgery and (2) not undergone surgery. RESULTS: A total of 908 patients underwent bariatric surgery (880 patients at our institution and 28 patients elsewhere). A total of 112 patients did not undergo surgery. Data regarding surgery on 165 patients could not be obtained. The mortality in those patients who did not undergo surgery was 14.3% compared with 2.9% for those who did undergo surgery. Adjusting for age, gender, and body mass index, patients who had undergone surgery had an 82% reduction in mortality (hazard ratio 0.18, 95% confidence interval 0.09-0.35, P <.0001). Sensitivity analysis, assuming that all patients with missing data received surgery resulted in an 85% mortality reduction (P <.001) and assuming that patients did not receive surgery resulted in a 50% mortality reduction (P = .04). CONCLUSIONS: Mortality among morbidly obese patients without surgery was 14.3% during the study period. Surgical intervention offered a 50%-85% mortality reduction benefit. 相似文献
64.
65.
66.
Robert M Bennett Jessie Jones Dennis C Turk I Jon Russell Lynne Matallana 《BMC musculoskeletal disorders》2007,8(1):27
Background
This study explored the feasibility of using an Internet survey of people with fibromyalgia (FM), with a view to providing information on demographics, sources of information, symptoms, functionality, perceived aggravating factors, perceived triggering events, health care utilization, management strategies, and medication use. 相似文献67.
Background
Within cluster randomized trials no algorithms exist to generate a full enumeration of a block randomization, balancing for covariates across treatment arms. Furthermore, often for practical reasons multiple blocks are required to fully randomize a study, which may not have been well balanced within blocks. 相似文献68.
Petra Mullner Simon E.F. Spencer Daniel J. Wilson Geoff Jones Alasdair D. Noble Anne C. Midwinter Julie M. Collins-Emerson Philip Carter Steve Hathaway Nigel P. French 《Infection, genetics and evolution》2009,9(6):1311-1319
Integrated surveillance of infectious multi-source diseases using a combination of epidemiology, ecology, genetics and evolution can provide a valuable risk-based approach for the control of important human pathogens. This includes a better understanding of transmission routes and the impact of human activities on the emergence of zoonoses. Until recently New Zealand had extraordinarily high and increasing rates of notified human campylobacteriosis, and our limited understanding of the source of these infections was hindering efforts to control this disease. Genetic and epidemiological modeling of a 3-year dataset comprising multilocus sequence typed isolates from human clinical cases, coupled with concurrent data on food and environmental sources, enabled us to estimate the relative importance of different sources of human disease. Our studies provided evidence that poultry was the leading cause of human campylobacteriosis in New Zealand, causing an estimated 58–76% of cases with widely varying contributions by individual poultry suppliers. These findings influenced national policy and, after the implementation of poultry industry-specific interventions, a dramatic decline in human notified cases was observed in 2008. The comparative-modeling and molecular sentinel surveillance approach proposed in this study provides new opportunities for the management of zoonotic diseases. 相似文献
69.
Botulinum Toxin A in the Treatment of Chromhidrosis 总被引:1,自引:0,他引:1
Wu Jessie M. Mamelak Adam J. MD † Nussbaum Rachel MD † McElgunn Patrick S. J. MD MBA † 《Dermatologic surgery》2005,31(8):963-965
Background. Chromhidrosis is an uncommon disorder characterized by secretion of colored sweat by apocrine glands, typically localized to the face or axilla. The current treatments available for chromhidrosis are time consuming and frequently ineffective.
Objective. Our purpose is to demonstrate a novel approach to the treatment of apocrine chromhidrosis.
Methods. We report a case of apocrine chromhidrosis successfully treated with botulinum toxin A (BTX-A; Botox).
Results. BTX-A therapy successfully controlled facial chromhidrosis, and the effects were visible at 19 weeks post-treatment. The therapeutic benefits may be attributed to its inhibitory effects on cholinergic stimulation, adrenergic stimulation, and substance P release, although further studies are necessary to elucidate the precise mechanism of action.
Conclusion. This report demonstrates a new therapeutic approach to patients suffering from chromhidrosis. 相似文献
Objective. Our purpose is to demonstrate a novel approach to the treatment of apocrine chromhidrosis.
Methods. We report a case of apocrine chromhidrosis successfully treated with botulinum toxin A (BTX-A; Botox).
Results. BTX-A therapy successfully controlled facial chromhidrosis, and the effects were visible at 19 weeks post-treatment. The therapeutic benefits may be attributed to its inhibitory effects on cholinergic stimulation, adrenergic stimulation, and substance P release, although further studies are necessary to elucidate the precise mechanism of action.
Conclusion. This report demonstrates a new therapeutic approach to patients suffering from chromhidrosis. 相似文献
70.
J.P. Jansen L. Webster J. Peppin B. Lasko J. Snidow A. Pierce E. Mortensen C. Kleoudis E. Carter 《European Journal of Pain》2006,10(Z1):S177b-S177